K Nael1, A Meshksar2, B Ellingson3, M Pirastehfar3, N Salamon3, P Finn3, D S Liebeskind4, J P Villablanca3. 1. From the Department of Medical Imaging (K.N., A.M.), University of Arizona, Tucson, Arizona kambiz@radiology.arizona.edu. 2. From the Department of Medical Imaging (K.N., A.M.), University of Arizona, Tucson, Arizona. 3. Department of Radiological Sciences (B.E., M.P., N.S., P.F., J.P.V.). 4. Department of Neurology, Stroke Center (D.S.L.), University of California, Los Angeles, Los Angeles, California.
Abstract
BACKGROUND AND PURPOSE: There is need to improve image acquisition speed for MR imaging in evaluation of patients with acute ischemic stroke. The purpose of this study was to evaluate the feasibility of a 3T MR stroke protocol that combines low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion, without additional contrast. METHODS: Thirty patients with acute stroke who underwent 3T MR imaging followed by DSA were retrospectively enrolled. TOF-MRA of the neck and brain and 3D contrast-enhanced MRA of the craniocervical arteries were obtained. A total of 0.1 mmol/kg of gadolinium was used for both contrast-enhanced MRA (0.05 mmol/kg) and dynamic susceptibility contrast perfusion (0.05 mmol/kg) (referred to as half-dose). An age-matched control stroke population underwent TOF-MRA and full-dose (0.1 mmol/kg) dynamic susceptibility contrast perfusion. The cervicocranial arteries were divided into 25 segments. Degree of arterial stenosis on contrast-enhanced MRA and TOF-MRA was compared with DSA. Time-to-maximum maps (>6 seconds) were evaluated for image quality and hypoperfusion. Quantitative analysis of arterial input function curves, SNR, and maximum T2* effects were compared between half- and full-dose groups. RESULTS: The intermodality agreements (k) for arterial stenosis were 0.89 for DSA/contrast-enhanced MRA and 0.63 for DSA/TOF-MRA. Detection specificity of >50% arterial stenosis was lower for TOF-MRA (89%) versus contrast-enhanced MRA (97%) as the result of overestimation of 10% (39/410) of segments by TOF-MRA. The DWI-perfusion mismatch was identified in both groups with high interobserver agreement (r = 1). There was no significant difference between full width at half maximum of the arterial input function curves (P = .14) or the SNR values (0.6) between the half-dose and full-dose groups. CONCLUSIONS: In patients with acute stroke, combined low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion at 3T is feasible and results in significant scan time and contrast dose reductions.
BACKGROUND AND PURPOSE: There is need to improve image acquisition speed for MR imaging in evaluation of patients with acute ischemic stroke. The purpose of this study was to evaluate the feasibility of a 3T MR stroke protocol that combines low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion, without additional contrast. METHODS: Thirty patients with acute stroke who underwent 3T MR imaging followed by DSA were retrospectively enrolled. TOF-MRA of the neck and brain and 3D contrast-enhanced MRA of the craniocervical arteries were obtained. A total of 0.1 mmol/kg of gadolinium was used for both contrast-enhanced MRA (0.05 mmol/kg) and dynamic susceptibility contrast perfusion (0.05 mmol/kg) (referred to as half-dose). An age-matched control stroke population underwent TOF-MRA and full-dose (0.1 mmol/kg) dynamic susceptibility contrast perfusion. The cervicocranial arteries were divided into 25 segments. Degree of arterial stenosis on contrast-enhanced MRA and TOF-MRA was compared with DSA. Time-to-maximum maps (>6 seconds) were evaluated for image quality and hypoperfusion. Quantitative analysis of arterial input function curves, SNR, and maximum T2* effects were compared between half- and full-dose groups. RESULTS: The intermodality agreements (k) for arterial stenosis were 0.89 for DSA/contrast-enhanced MRA and 0.63 for DSA/TOF-MRA. Detection specificity of >50% arterial stenosis was lower for TOF-MRA (89%) versus contrast-enhanced MRA (97%) as the result of overestimation of 10% (39/410) of segments by TOF-MRA. The DWI-perfusion mismatch was identified in both groups with high interobserver agreement (r = 1). There was no significant difference between full width at half maximum of the arterial input function curves (P = .14) or the SNR values (0.6) between the half-dose and full-dose groups. CONCLUSIONS: In patients with acute stroke, combined low-dose contrast-enhanced MRA and dynamic susceptibility contrast perfusion at 3T is feasible and results in significant scan time and contrast dose reductions.
Authors: Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase Journal: Magn Reson Med Date: 2002-06 Impact factor: 4.668
Authors: Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen Journal: Magn Reson Med Date: 2003-07 Impact factor: 4.668
Authors: K S Butcher; M Parsons; L MacGregor; P A Barber; J Chalk; C Bladin; C Levi; T Kimber; D Schultz; J Fink; B Tress; G Donnan; S Davis Journal: Stroke Date: 2005-06 Impact factor: 7.914
Authors: Kambiz Nael; J Pablo Villablanca; Whitney B Pope; Thomas O McNamara; Gerhard Laub; J Paul Finn Journal: Radiology Date: 2007-02 Impact factor: 11.105
Authors: Ioannis Koktzoglou; Rong Huang; Archie L Ong; Pascale J Aouad; Matthew T Walker; Robert R Edelman Journal: Magn Reson Med Date: 2020-06-10 Impact factor: 4.668
Authors: K Nael; B Mossadeghi; T Boutelier; W Kubal; E A Krupinski; J Dagher; J P Villablanca Journal: AJNR Am J Neuroradiol Date: 2014-11-27 Impact factor: 3.825
Authors: Liam Timms; Tianyi Zhou; Yue Lyu; Ju Qiao; Vishala Mishra; Rita Maria Lahoud; Gayatri Veeramani Jayaraman; Andrew S Allegretti; David Drew; Ravi T Seethamraju; Mukesh Harisinghani; Srinivas Sridhar Journal: Abdom Radiol (NY) Date: 2021-03-05
Authors: Søren Christensen; Shalini Amukotuwa; Maarten G Lansberg; Stephanie Kemp; Jeremy J Heit; Michael Mlynash; Michael P Marks; Greg W Albers; Roland Bammer Journal: J Cereb Blood Flow Metab Date: 2020-03-24 Impact factor: 6.960